Gerrit Dispersyn
2022
In 2022, Gerrit Dispersyn earned a total compensation of $489.8K as Former President and Chief Executive Officer at RXi Pharmaceuticals, a 35% decrease compared to previous year.
Compensation breakdown
| Salary | $178,514 |
|---|---|
| Stock Awards | $108,511 |
| Other | $202,744 |
| Total | $489,769 |
Dispersyn received $202.7K in other compensation, accounting for 41% of the total pay in 2022.
Dispersyn also received $178.5K in salary and $108.5K in stock awards.
Rankings
In 2022, Gerrit Dispersyn's compensation ranked 4,377th out of 5,760 executives tracked by ExecPay. In other words, Dispersyn earned more than 24.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,377 out of 5,760 | 24th |
Division Manufacturing | 2,460 out of 3,136 | 22nd |
Major group Chemicals And Allied Products | 1,192 out of 1,422 | 16th |
Industry group Drugs | 1,119 out of 1,323 | 15th |
Industry Pharmaceutical Preparations | 817 out of 969 | 16th |
Source: SEC filing on June 9, 2023.
Dispersyn's colleagues
We found two more compensation records of executives who worked with Gerrit Dispersyn at RXi Pharmaceuticals in 2022.